Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PRE-SATE

CHLORPHENTERMINE HYDROCHLORIDE

Standard Dose
EQ 65MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview PRE-SATE is listed in Drugs@FDA under application 014696 (NDA).

Marketing status: Discontinued Active ingredient CHLORPHENTERMINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 65MG BASE Sponsor PARKE DAVIS Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview PRE-SATE is listed in Drugs@FDA under application 014696 (NDA). Marketing status: Discontinued Active ingredient CHLORPHENTERMINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 65MG BASE Sponsor PARKE DAVIS Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
PRE-SATE (CHLORPHENTERMINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline